Literature DB >> 12438408

Plasmodium falciparum serine repeat protein, a new target of monocyte-dependent antibody-mediated parasite killing.

Soe Soe1, Subhash Singh, Daniel Camus, Toshihiro Horii, Pierre Druilhe.   

Abstract

Using monoclonal antibodies and human affinity-purified antibodies specific to the Plasmodium falciparum 126-kDa serine-rich protein, SERP, we found that these antibodies have no direct effect upon merozoite invasion at the concentrations tested but can cooperate with blood monocytes to strongly inhibit P. falciparum in vitro growth.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12438408      PMCID： PMC133104          DOI： 10.1128/IAI.70.12.7182-7184.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  A 50 kilodalton exoantigen specific to the merozoite release-reinvasion stage of Plasmodium falciparum.

Authors:  P Delplace; J F Dubremetz; B Fortier; A Vernes
Journal:  Mol Biochem Parasitol       Date:  1985-11       Impact factor: 1.759

2.  Enzyme immunoassay for detection of antigen in acute Plasmodium falciparum malaria.

Authors:  B Fortier; P Delplace; J F Dubremetz; F Ajana; A Vernes
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

Review 3.  Immunity to blood stages of malaria.

Authors:  C A Long
Journal:  Curr Opin Immunol       Date:  1993-08       Impact factor: 7.486

4.  Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates.

Authors:  K Brahimi; J L Pérignon; M Bossus; H Gras; A Tartar; P Druilhe
Journal:  J Immunol Methods       Date:  1993-06-04       Impact factor: 2.303

5.  Isolation and characterization of parasite-inhibitory Plasmodium falciparum monoclonal antibodies.

Authors:  H S Banyal; J Inselburg
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

6.  Natural human immunoglobulin G subclass responses to Plasmodium falciparum serine repeat antigen in Uganda.

Authors:  B A Okech; A Nalunkuma; D Okello; X L Pang; K Suzue; J Li; T Horii; T G Egwang
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

7.  Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts.

Authors:  X L Pang; T Mitamura; T Horii
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

8.  Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum.

Authors:  J Inselburg; D J Bzik; W B Li; K M Green; J Kansopon; B K Hahm; I C Bathurst; P J Barr; R N Rossan
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

9.  Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.

Authors:  L H Perrin; B Merkli; M Loche; C Chizzolini; J Smart; R Richle
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.

Authors:  H Bouharoun-Tayoun; P Attanath; A Sabchareon; T Chongsuphajaisiddhi; P Druilhe
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307
View more
  9 in total

1.  Comparative Immunogenicities of full-length Plasmodium falciparum merozoite surface protein 3 and a 24-kilodalton N-terminal fragment.

Authors:  Maryam Imam; Yengkhom Sangeeta Devi; Akhilesh K Verma; Virander Singh Chauhan
Journal:  Clin Vaccine Immunol       Date:  2011-06-01

2.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

Authors:  Corine G Demanga; Lena-Juliette Daher; Eric Prieur; Catherine Blanc; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

3.  Understanding human-Plasmodium falciparum immune interactions uncovers the immunological role of worms.

Authors:  Christian Roussilhon; Philippe Brasseur; Patrice Agnamey; Jean-Louis Pérignon; Pierre Druilhe
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

4.  Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda.

Authors:  Masanori Yagi; Nirianne M Q Palacpac; Kazuya Ito; Yuko Oishi; Sawako Itagaki; Betty Balikagala; Edward H Ntege; Adoke Yeka; Bernard N Kanoi; Osbert Katuro; Hiroki Shirai; Wakaba Fukushima; Yoshio Hirota; Thomas G Egwang; Toshihiro Horii
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

5.  Proteomic analysis of microparticles isolated from malaria positive blood samples.

Authors:  Samuel Antwi-Baffour; Jonathan Kofi Adjei; Francis Agyemang-Yeboah; Max Annani-Akollor; Ransford Kyeremeh; George Awuku Asare; Ben Gyan
Journal:  Proteome Sci       Date:  2017-03-24       Impact factor: 2.480

6.  Molecular Camouflage of Plasmodium falciparum Merozoites by Binding of Host Vitronectin to P47 Fragment of SERA5.

Authors:  Takahiro Tougan; Jyotheeswara R Edula; Eizo Takashima; Masayuki Morita; Miki Shinohara; Akira Shinohara; Takafumi Tsuboi; Toshihiro Horii
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

7.  Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon.

Authors:  Lilian Rose Pratt-Riccio; Selma Sallenave-Sales; Joseli de Oliveira-Ferreira; Bruno T da Silva; Monick Lindenmeyer Guimarães; Fátima Santos; Thatiane S de Simone; Mariza G Morgado; Salvatore G de Simone; Maria de Fátima Ferreira-Da-Cruz; Cláudio T Daniel-Ribeiro; Mariano G Zalis; Daniel Camus; Dalma M Banic
Journal:  Malar J       Date:  2008-07-30       Impact factor: 2.979

8.  Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome.

Authors:  David Llewellyn; Simone C de Cassan; Andrew R Williams; Alexander D Douglas; Emily K Forbes; Jaime R Adame-Gallegos; Jianguo Shi; Richard J Pleass; Simon J Draper
Journal:  J Leukoc Biol       Date:  2013-10-25       Impact factor: 4.962

9.  Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences.

Authors:  Masanori Yagi; Gilles Bang; Takahiro Tougan; Nirianne M Q Palacpac; Nobuko Arisue; Taiki Aoshi; Yoshitsugu Matsumoto; Ken J Ishii; Thomas G Egwang; Pierre Druilhe; Toshihiro Horii
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.